Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DTIL
DTIL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DTIL News
iECURE's ECUR-506 Selected for FDA CMC Program
Mar 18 2026
Newsfilter
Precision BioSciences Q4 Earnings Exceed Expectations
Mar 12 2026
seekingalpha
Precision BioSciences Unveils PBGENE-HBV Clinical Data at AASLD
Mar 12 2026
Newsfilter
Precision BioSciences to Announce Q4 Earnings on March 12
Mar 11 2026
seekingalpha
Precision BioSciences Secures Two Patent Allowances
Mar 11 2026
Newsfilter
Precision BioSciences Secures Two Patent Allowances
Mar 11 2026
Yahoo Finance
PBGENE-DMD Treatment Shows Durable Efficacy
Mar 10 2026
Yahoo Finance
Precision BioSciences' PBGENE-DMD Receives FDA Fast Track Designation
Mar 09 2026
NASDAQ.COM
Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD
Mar 09 2026
Newsfilter
FDA Grants Fast Track Designation to PBGENE-DMD for DMD Treatment
Mar 09 2026
Yahoo Finance
FDA Approval Enables Initiation of DMD Clinical Trial
Feb 11 2026
Newsfilter
Precision BioSciences Receives FDA Approval for Clinical Trial
Feb 11 2026
Yahoo Finance
Precision BioSciences Advances PBGENE-HBV and PBGENE-DMD Trials, Data Updates Expected in 2026
Jan 12 2026
Yahoo Finance
iECURE Secures FDA RMAT Designation for ECUR-506, Advancing OTC Deficiency Treatment
Jan 07 2026
Newsfilter
Biotech Stocks Surge in After-Hours Trading with Gains from BioAtla, Entero, and Sonnet
Dec 01 2025
NASDAQ.COM
Precision BioSciences Initiates $75 Million Stock and Warrant Sale
Nov 11 2025
SeekingAlpha
Show More News
